These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32545331)

  • 1. Persistent Innate Immune Stimulation Results in IRF3-Mediated but Caspase-Independent Cytostasis.
    Urban C; Welsch H; Heine K; Wüst S; Haas DA; Dächert C; Pandey A; Pichlmair A; Binder M
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
    Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
    J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
    Horner SM; Park HS; Gale M
    J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
    Johnson CL; Owen DM; Gale M
    J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
    Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
    He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
    J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response.
    Ferreira AR; Magalhães AC; Camões F; Gouveia A; Vieira M; Kagan JC; Ribeiro D
    J Cell Mol Med; 2016 Apr; 20(4):750-7. PubMed ID: 26865163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDA5 plays a critical role in interferon response during hepatitis C virus infection.
    Cao X; Ding Q; Lu J; Tao W; Huang B; Zhao Y; Niu J; Liu YJ; Zhong J
    J Hepatol; 2015 Apr; 62(4):771-8. PubMed ID: 25463548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.
    Chen Z; Benureau Y; Rijnbrand R; Yi J; Wang T; Warter L; Lanford RE; Weinman SA; Lemon SM; Martin A; Li K
    J Virol; 2007 Jan; 81(2):964-76. PubMed ID: 17093192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.
    Ding Q; Cao X; Lu J; Huang B; Liu YJ; Kato N; Shu HB; Zhong J
    J Hepatol; 2013 Jul; 59(1):52-8. PubMed ID: 23542348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
    Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
    Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses.
    Qu L; Lemon SM
    Semin Liver Dis; 2010 Nov; 30(4):319-32. PubMed ID: 20960373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importin β1 targeting by hepatitis C virus NS3/4A protein restricts IRF3 and NF-κB signaling of IFNB1 antiviral response.
    Gagné B; Tremblay N; Park AY; Baril M; Lamarre D
    Traffic; 2017 Jun; 18(6):362-377. PubMed ID: 28295920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
    Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
    J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergent evolution of escape from hepaciviral antagonism in primates.
    Patel MR; Loo YM; Horner SM; Gale M; Malik HS
    PLoS Biol; 2012; 10(3):e1001282. PubMed ID: 22427742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.
    Bender S; Reuter A; Eberle F; Einhorn E; Binder M; Bartenschlager R
    PLoS Pathog; 2015 Nov; 11(11):e1005264. PubMed ID: 26588843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3.
    Ning X; Wang Y; Jing M; Sha M; Lv M; Gao P; Zhang R; Huang X; Feng JM; Jiang Z
    Mol Cell; 2019 Apr; 74(1):19-31.e7. PubMed ID: 30878284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction.
    Ning YJ; Feng K; Min YQ; Deng F; Hu Z; Wang H
    J Biol Chem; 2017 Oct; 292(40):16722-16733. PubMed ID: 28848048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
    Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
    Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.